Neural activity related to drug craving in cocaine addiction.

Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22

Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci (2008) 4.60

Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) (2006) 4.23

The addicted human brain: insights from imaging studies. J Clin Invest (2003) 3.91

The hidden island of addiction: the insula. Trends Neurosci (2008) 3.28

Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) (2003) 3.24

Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2002) 2.79

Impulsivity, frontal lobes and risk for addiction. Pharmacol Biochem Behav (2009) 2.56

Prefrontal responses to drug cues: a neurocognitive analysis. Nat Neurosci (2004) 2.35

Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev (2011) 2.30

Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci Biobehav Rev (2007) 2.20

Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence. Am J Psychiatry (2012) 2.19

Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues. Neuropsychopharmacology (2005) 2.12

The neurocircuitry of addiction: an overview. Br J Pharmacol (2008) 2.11

Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol (2008) 2.06

Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience (2006) 1.93

Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2005) 1.84

Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology (2008) 1.84

Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine. Neuron (2009) 1.81

The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev (2005) 1.80

Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry (2008) 1.80

Behavioral characteristics and neurobiological substrates shared by Pavlovian sign-tracking and drug abuse. Brain Res Rev (2007) 1.75

Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2007) 1.69

Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) (2008) 1.67

Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage (2007) 1.66

Altered cingulate and insular cortex activation during risk-taking in methamphetamine dependence: losses lose impact. Addiction (2013) 1.63

Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev (2010) 1.61

Instructed smoking expectancy modulates cue-elicited neural activity: a preliminary study. Nicotine Tob Res (2005) 1.60

A somatic marker theory of addiction. Neuropharmacology (2008) 1.59

Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res (2004) 1.55

Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev (2013) 1.54

Interoceptive basis to craving. Neuron (2007) 1.53

Activation in the VTA and nucleus accumbens increases in anticipation of both gains and losses. Front Behav Neurosci (2009) 1.53

The role of acetylcholine in cocaine addiction. Neuropsychopharmacology (2007) 1.50

Cerebellar lingula size and experiential risk factors associated with high levels of alcohol and drug use in young adults. Cerebellum (2010) 1.49

Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry (2005) 1.47

Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46

Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory. J Neurosci (2011) 1.40

Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism. Mol Psychiatry (2011) 1.39

Anterior insular cortex anticipates impending stimulus significance. Neuroimage (2009) 1.38

A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research. Can J Psychiatry (2013) 1.37

Prescription opioid analgesics rapidly change the human brain. Pain (2011) 1.34

Interoception and drug addiction. Neuropharmacology (2013) 1.30

Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol (2010) 1.30

Emotional imagery: assessing pleasure and arousal in the brain's reward circuitry. Hum Brain Mapp (2010) 1.27

Neural substrates of cognitive inflexibility after chronic cocaine exposure. Neuropharmacology (2008) 1.23

Is there evidence for neural compensation in attention deficit hyperactivity disorder? A review of the functional neuroimaging literature. Clin Psychol Rev (2006) 1.20

Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction. Neurosci Biobehav Rev (2010) 1.19

The role of histone acetylation in cocaine-induced neural plasticity and behavior. Neuropsychopharmacology (2012) 1.19

Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav Brain Res (2011) 1.18

NMDA receptor blockade in the basolateral amygdala disrupts consolidation of stimulus-reward memory and extinction learning during reinstatement of cocaine-seeking in an animal model of relapse. Neurobiol Learn Mem (2007) 1.17

Effects of mGluR1 antagonism in the dorsal hippocampus on drug context-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2009) 1.17

Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev (2010) 1.15

Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry (2011) 1.14

Involvement of insula and cingulate cortices in control and suppression of natural urges. Cereb Cortex (2008) 1.14

Divergent plasticity of prefrontal cortex networks. Neuropsychopharmacology (2007) 1.12

Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl) (2011) 1.12

Identification of hyperactive intrinsic amygdala network connectivity associated with impulsivity in abstinent heroin addicts. Behav Brain Res (2010) 1.12

Forced abstinence model of relapse to study pharmacological treatments of substance use disorder. Curr Drug Abuse Rev (2009) 1.11

Adult neurogenesis and the memories of drug addiction. Eur Arch Psychiatry Clin Neurosci (2007) 1.09

New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep (2011) 1.09

Reduced metabolism in brain "control networks" following cocaine-cues exposure in female cocaine abusers. PLoS One (2011) 1.09

Anatomical differences and network characteristics underlying smoking cue reactivity. Neuroimage (2010) 1.08

Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction. Psychopharmacology (Berl) (2006) 1.08

N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology (2012) 1.07

Neurobiological dissociation of retrieval and reconsolidation of cocaine-associated memory. J Neurosci (2013) 1.07

Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. Pharmacol Rev (2015) 1.06

Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol (2010) 1.02

Neural basis of reward and craving--a homeostatic point of view. Dialogues Clin Neurosci (2007) 1.01

Sub-region specific contribution of the ventral hippocampus to drug context-induced reinstatement of cocaine-seeking behavior in rats. Neuroscience (2010) 1.01

Serotonergic mechanisms in addiction-related memories. Behav Brain Res (2008) 1.01

Temporal decision-making: insights from cognitive neuroscience. Front Behav Neurosci (2009) 1.01

Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers. PLoS One (2010) 1.01

Contextual cues associated with nicotine administration increase arc mRNA expression in corticolimbic areas of the rat brain. Eur J Neurosci (2005) 1.00

The clinical neurobiology of drug craving. Curr Opin Neurobiol (2013) 0.99

Timing-dependent regulation of evoked spiking in nucleus accumbens neurons by integration of limbic and prefrontal cortical inputs. J Neurophysiol (2009) 0.99

Addictive nicotine alters local circuit inhibition during the induction of in vivo hippocampal synaptic potentiation. J Neurosci (2010) 0.99

Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2010) 0.99

Altered neural cholinergic receptor systems in cocaine-addicted subjects. Neuropsychopharmacology (2010) 0.99

Cortical activation during cocaine use and extinction in rhesus monkeys. Psychopharmacology (Berl) (2009) 0.99

Regional grey and white matter changes in heavy male smokers. PLoS One (2011) 0.98

Interaction of the basolateral amygdala and orbitofrontal cortex is critical for drug context-induced reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology (2010) 0.97

Connectivity strength of dissociable striatal tracts predict individual differences in temporal discounting. J Neurosci (2014) 0.97

Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia. Psychopharmacology (Berl) (2008) 0.96

Neuropsychiatric effects of cocaine use disorders. J Natl Med Assoc (2005) 0.95

Glutamatergic targets for enhancing extinction learning in drug addiction. Curr Neuropharmacol (2010) 0.95

Cortical thickness abnormalities in late adolescence with online gaming addiction. PLoS One (2013) 0.95

Emotion, decision-making and substance dependence: a somatic-marker model of addiction. Curr Neuropharmacol (2006) 0.94

Counteracting incentive sensitization in severe alcohol dependence using deep brain stimulation of the nucleus accumbens: clinical and basic science aspects. Front Hum Neurosci (2009) 0.94

Brain-derived neurotrophic factor-estrogen interactions in the hippocampal mossy fiber pathway: implications for normal brain function and disease. Neuroscience (2012) 0.94

The cerebellum and addiction: insights gained from neuroimaging research. Addict Biol (2014) 0.94

The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol (2010) 0.93

Overlapping patterns of brain activation to food and cocaine cues in cocaine abusers: association to striatal D2/D3 receptors. Hum Brain Mapp (2014) 0.93

The influences of task difficulty and response correctness on neural systems supporting fluid reasoning. Cogn Neurodyn (2006) 0.92

Removal of perineuronal nets in the medial prefrontal cortex impairs the acquisition and reconsolidation of a cocaine-induced conditioned place preference memory. J Neurosci (2015) 0.92

Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry (2006) 0.91

Historical and current perspective on tobacco use and nicotine addiction. Trends Neurosci (2011) 0.91

Neural responses to BEGIN- and END-stimuli of the smoking ritual in nonsmokers, nondeprived smokers, and deprived smokers. Neuropsychopharmacology (2010) 0.91

Different pattern of brain c-Fos expression following re-exposure to ethanol or sucrose self-administration environment. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.90

Investigation of the neuroanatomical substrates of reward seeking following protracted abstinence in mice. J Physiol (2012) 0.90

THE EFFECTS OF THE PATENT DUCTUS ARTERIOSUS ON THE CIRCULATION. J Clin Invest (1941) 7.11

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J Virol (1991) 7.01

SURGICAL MANAGEMENT OF THE PATENT DUCTUS ARTERIOSUS: WITH SUMMARY OF FOUR SURGICALLY TREATED CASES. Ann Surg (1939) 5.76

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13

Tissue-culture Evaluation of the Viability of Blood Vessels Stored by Refrigeration. Ann Surg (1949) 4.24

Sclerosing Hemangiomas: Their Relationship to Dermatofibroma, Histiocytoma, Xanthoma and to Certain Pigmented Lesions of the Skin. Am J Pathol (1943) 4.16

Direct text entry in electronic progress notes. An evaluation of input errors. Methods Inf Med (2003) 4.00

Amygdala activity related to enhanced memory for pleasant and aversive stimuli. Nat Neurosci (1999) 3.33

Hazard of overwhelming infection after splenectomy in childhood. N Engl J Med (1967) 3.14

THE SURGICAL TREATMENT OF TUMORS OF THE PERIPHERAL NERVES. Ann Surg (1936) 2.96

Surgical Treatment for Dysphagia Lusoria. Ann Surg (1946) 2.88

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Proc Natl Acad Sci U S A (1991) 2.67

The intermediate endpoint effect in logistic and probit regression. Clin Trials (2007) 2.67

Congenital Cystic Lung: Successful Pneumonectomy in a Three-Week-Old Baby. Ann Surg (1946) 2.66

Congenital coronary artery fistula. Surgery (1969) 2.62

Cognitive deficits in patients with essential tremor. Neurology (2001) 2.27

Annular Pancreas Producing Duodenal Obstruction : Report of a Successfully Treated Case. Ann Surg (1944) 2.15

A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin Pharmacol Ther (2012) 2.12

Performance characteristics of a whole-body PET scanner. J Nucl Med (1994) 2.08

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol (1991) 2.05

Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord (1997) 1.69

A review of 164 children with meconium ileus seen at the Children's Hospital Medical Center, Boston. Pediatrics (1966) 1.68

Role of posterior parietal cortex in the recalibration of visually guided reaching. Nature (1996) 1.66

[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol (1993) 1.62

Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology (1997) 1.56

Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties. J Neurosci (1988) 1.55

Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology (1993) 1.54

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology (1993) 1.53

Diagnosis and surgical treatment of infants with critical pulmonary outflow obstruction. Study of thirty-four infants with pulmonary stenosis or atresia, and intact ventricular septum. Circulation (1967) 1.52

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med (1987) 1.51

The reduction of postlaminectomy peridural fibrosis in rabbits by a carbohydrate polymer. J Neurosurg (1993) 1.51

Beam quality independent attenuation phantom for estimating patient exposure from x-ray automatic exposure controlled chest examinations. Med Phys (1985) 1.46

Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am J Psychiatry (2000) 1.45

PGY1. J Am Coll Dent (1996) 1.40

Child abuse in the dental operatory. N Y State Dent J (1989) 1.39

Clinical validation of three-dimensional color-modulated displays of myocardial perfusion. J Nucl Cardiol (1997) 1.39

Plenty of blame to go around. N Y State Dent J (1998) 1.38

Compensatory recruitment of neural resources during overt rehearsal of word lists in Alzheimer's disease. Neuropsychology (1998) 1.31

Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med (1994) 1.30

Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology (1999) 1.29

Prevention of postoperative intestinal adhesions with combined promethazine and dexamethasone therapy: experimental and clinical studies. Ann Surg (1966) 1.26

Role of nitric oxide in inflammation. Acta Physiol Scand (2001) 1.25

Transposition of the great arteries: clinical and physiological observations on 74 patients treated by palliative surgery. Circulation (1968) 1.23

18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol (2000) 1.21

Nerve growth factor receptor molecules in rat brain. Proc Natl Acad Sci U S A (1986) 1.21

Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. J Nucl Med (1995) 1.19

Feeling with the mind's eye. Neuroreport (1997) 1.19

Blunt abdominal trauma in infancy and childhood. J Trauma (1968) 1.19

Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. Arch Neurol (1992) 1.18

Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia (1998) 1.17

2-Pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors. J Med Chem (1991) 1.16

Determining the accuracy of calculating systolic wall thickening using a fast Fourier transform approximation: a simulation study based on canine and patient data. J Nucl Med (1994) 1.13

Effects of dexamethasone and chlorpromazine on skeletal muscle surface hydrogen ion concentration during cardiopulmonary bypass: experimental and clinical results. Ann Surg (1972) 1.12

Motor subcircuits mediating the control of movement velocity: a PET study. J Neurophysiol (1998) 1.11

DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol (1995) 1.10

Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. J Nucl Med (1999) 1.09

An apparatus and behavioral training protocol to conduct positron emission tomography (PET) neuroimaging in conscious rhesus monkeys. J Neurosci Methods (2001) 1.09

Photoinhibition of growth of a yellow and colorless form of Chlamydomonas reinhardtii. Photochem Photobiol (1969) 1.09

Neural correlates of maternal separation in rhesus monkeys. Biol Psychiatry (2001) 1.08

Rapid dual-injection single-scan 13N-ammonia PET for quantification of rest and stress myocardial blood flows. Phys Med Biol (2006) 1.07

Neural evidence linking visual object enumeration and attention. J Cogn Neurosci (1999) 1.05

Progress and problems in the surgical management of congenital aortic stenosis. J Thorac Cardiovasc Surg (1973) 1.04

Insulin receptors: differences in structural organization on adipocyte and liver plasma membranes. Science (1980) 1.03

Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS (1997) 1.03

FDG-PET in patients at risk for acute respiratory distress syndrome: a preliminary report. Intensive Care Med (2008) 1.02

Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med (1992) 1.01

A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease. Ann Neurol (1990) 1.01

Studies on the hemodynamic importance of blood viscosity. J Thorac Cardiovasc Surg (1965) 1.01

Seroprevalence of Toxoplasma gondii in sheep and goats in Rahim Yar Khan (Punjab), Pakistan. Trop Anim Health Prod (2009) 0.99

Aneurysms of right ventricular outflow patches. J Thorac Cardiovasc Surg (1972) 0.99

Clinical application of PET for the evaluation of brain tumors. J Nucl Med (1991) 0.99

Wisconsin Card Sorting Test performance following head injury: dorsolateral fronto-striatal circuit activity predicts perseveration. J Clin Exp Neuropsychol (1999) 0.99

Some hematologic aspects of prolonged blood pumping. Observations from a series of paired perfusions. J Thorac Cardiovasc Surg (1967) 0.99

SURGICAL ANASTOMOSES BETWEEN THE BILIARY AND INTESTINAL TRACTS OF CHILDREN: FOLLOW-UP STUDIES. Ann Surg (1940) 0.98

The effects of immunolesions of nerve growth factor-receptive neurons by 192 IgG-saporin on sleep. Brain Res (1996) 0.98

Surgical management of aortopulmonary fenestration. Surgery (1966) 0.98

Adult age differences in regional cerebral blood flow during visual world identification: evidence from H215O PET. Neuroimage (1996) 0.97

Selective destruction of nerve growth factor receptor-bearing cells in vitro using a hybrid toxin composed of ricin A chain and a monoclonal antibody against the nerve growth factor receptor. J Cell Biol (1985) 0.97

Intussusception as a postoperative complication. Surgery (1968) 0.97

Cutaneous ureteroileostomy in children. N Engl J Med (1967) 0.97

Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal (2000) 0.96

Congenital pulmonary atresia with ventricular septal defect. Review of the clinical course of fifty patients with assessment of the results of palliative surgery. Am J Cardiol (1968) 0.96

Landmark article Feb 25, 1939: Surgical ligation of a patent ductus arteriosus. Report of first successful case. By Robert E. Gross and John P. Hubbard. JAMA (1984) 0.95

Activation of 5-HT1A receptors in medullary raphé disrupts sleep and decreases shivering during cooling in the conscious piglet. Am J Physiol Regul Integr Comp Physiol (2007) 0.94

L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro. Antimicrob Agents Chemother (1992) 0.93

Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: attenuation by diazepam. Brain Res (1992) 0.92

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one. J Med Chem (1992) 0.92

Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat. Neuroscience (1997) 0.92

Selective and divided visual attention: age-related changes in regional cerebral blood flow measured by H2(15)O PET. Hum Brain Mapp (1997) 0.91

Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology (1994) 0.91

Congenital posterolateral diaphragmatic hernia in the newborn. J Thorac Cardiovasc Surg (1968) 0.91

Neonatal peritonitis. Surgery (1967) 0.91

Enhanced post-ischemic liver injury in iNOS-deficient mice: a cautionary note. Biochem Biophys Res Commun (2001) 0.91

Results of surgery of constrictive pericarditis in pediatric patients. Am J Surg (1970) 0.91

Specificity of 192 IgG-saporin for NGF receptor-positive cholinergic basal forebrain neurons in the rat. Brain Res (1992) 0.91